Loading clinical trials...
Loading clinical trials...
Multicenter Open-label Observation Program in Patients With Chronic Hepatitis C and With Chronic Renal Failure (CRF) Receiving Peginterferon Alpha-2a (40 kDa) Pegasys
Conditions
Interventions
peginterferon alfa-2a [Pegasys]
Locations
5
Russia
Chita, Russia
Irkutsk, Russia
Khabarovsk, Russia
Khabarovsk, Russia
Orenburg, Russia
Start Date
July 1, 2007
Primary Completion Date
June 1, 2011
Completion Date
June 1, 2011
Last Updated
July 25, 2016
NCT05870969
NCT03987503
NCT04382404
NCT01226797
NCT00062816
NCT04774107
Lead Sponsor
Hoffmann-La Roche
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions